2018. A Study on Safety and Efficacy of Sodium-glucose Cotransporter-2 Inhibitors as Adjuvant to Insulin Add-on Therapy in Uncontrolled Type 2 Diabetic Patients. Asian Journal of Pharmaceutics (AJP). 12, 03 (Nov. 2018). DOI:https://doi.org/10.22377/ajp.v12i03.2625.